Abstract
A human gastric adenocarcinoma cell line was used to evaluate the contribution of urease from Helicobacter (formerly Campylobacter) pylori to its cytotoxicity. Gastric cells cultured in medium supplemented with 20 mM urea were exposed to 5 x 10(6) CFU of H. pylori per ml with or without the addition of a urease inhibitor, acetohydroxamic acid. Viabilities of cells exposed to H. pylori for 2, 24, and 48 h, assessed by incorporation of neutral red dye, were 60, 27, and 16%, respectively; however, the viabilities of cells exposed to both H. pylori and acetohydroxamic acid were 92, 46, and 20% after 2, 24, and 48 h, respectively, (P less than 0.001). Therefore, the urease activity of H. pylori may play an important role in its pathogenicity, and inhibition of this enzyme activity may have therapeutic potential.
Full text
PDF![1992](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9f5/258755/3a7bc9b5e8f7/iai00054-0516.png)
![1993](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9f5/258755/0bffb26569a1/iai00054-0517.png)
![1994](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9f5/258755/2df5ce14c461/iai00054-0518.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barranco S. C., Townsend C. M., Jr, Casartelli C., Macik B. G., Burger N. L., Boerwinkle W. R., Gourley W. K. Establishment and characterization of an in vitro model system for human adenocarcinoma of the stomach. Cancer Res. 1983 Apr;43(4):1703–1709. [PubMed] [Google Scholar]
- Bruce A. W., Leiendecker C. M., Freier E. F. Two-point determination of plasma ammonia with the centrifugal analyzer. Clin Chem. 1978 May;24(5):782–787. [PubMed] [Google Scholar]
- Dooley C. P., Cohen H. The clinical significance of Campylobacter pylori. Ann Intern Med. 1988 Jan;108(1):70–79. doi: 10.7326/0003-4819-108-1-70. [DOI] [PubMed] [Google Scholar]
- Graham D. Y. Campylobacter pylori and peptic ulcer disease. Gastroenterology. 1989 Feb;96(2 Pt 2 Suppl):615–625. doi: 10.1016/s0016-5085(89)80057-5. [DOI] [PubMed] [Google Scholar]
- Marshall B. J., Armstrong J. A., McGechie D. B., Glancy R. J. Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med J Aust. 1985 Apr 15;142(8):436–439. doi: 10.5694/j.1326-5377.1985.tb113443.x. [DOI] [PubMed] [Google Scholar]
- Mobley H. L., Cortesia M. J., Rosenthal L. E., Jones B. D. Characterization of urease from Campylobacter pylori. J Clin Microbiol. 1988 May;26(5):831–836. doi: 10.1128/jcm.26.5.831-836.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Morris A., Nicholson G. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol. 1987 Mar;82(3):192–199. [PubMed] [Google Scholar]
- Olender E. J., Woods D., Kozol R., Fromm D. Salicylate effects on proton gradient dissipation by isolated gastric mucosal surface cells. Proc Soc Exp Biol Med. 1986 Nov;183(2):177–185. doi: 10.3181/00379727-183-42402. [DOI] [PubMed] [Google Scholar]